Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 56 | 0 | 16,828 | 0 | 18,772 |
| Cost of Goods | N/A | N/A | 26,570 | N/A | 24,997 |
| Gross Profit | 56 | N/A | -9,742 | N/A | -6,225 |
| Operating Expenses | 30,722 | 26,483 | 43,354 | 0 | 49,613 |
| Operating Income | -30,666 | -26,483 | -52,526 | N/A | -54,841 |
| Interest Expense | 2,457 | 2,489 | 2,302 | 0 | 2,321 |
| Other Income | -19 | -3,751 | -20 | 0 | 29 |
| Pre-tax Income | -33,142 | -32,723 | -54,848 | 0 | -57,133 |
| Income Tax | N/A | N/A | -37,696 | N/A | N/A |
| Net Income Continuous | -33,142 | -32,723 | -17,152 | N/A | -57,133 |
| Net Income Discontinuous | -13,923 | -20,060 | N/A | N/A | N/A |
| Net Income | $-47,065 | $-52,783 | $-17,152 | $N/A | $-57,133 |
| EPS Basic Total Ops | -25.25 | -152.75 | -85.75 | N/A | -496.25 |
| EPS Basic Continuous Ops | -17.75 | -94.25 | -85.88 | N/A | -289.66 |
| EPS Basic Discontinuous Ops | -7.50 | -57.75 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -25.25 | -152.75 | -85.75 | N/A | -496.25 |
| EPS Diluted Continuous Ops | -17.75 | -94.25 | -85.88 | N/A | -289.66 |
| EPS Diluted Discontinuous Ops | -7.50 | -57.75 | N/A | N/A | N/A |
| EBITDA(a) | $-29,827 | $-26,065 | $-50,825 | $N/A | $-53,237 |